FEED

SEC source: 0001493152-23-043638 · ownership.xml · derivative · entry 5

Goldstein Martin M · CIK 0001639061 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 3,000 shares

Expires 2030-12-22

F6 · price: The options were canceled by mutual agreement of the reporting person and NanoVibronix, Inc. The reporting person received $1.00 as the aggregate consideration for the cancellations.

F3 · derivative.exercise_date: 20% of the option vested on December 22, 2020 (the "2020 Date of Grant"), with an additional 20% vested on the three month anniversary of the 2020 Date of Grant, a further 20% vested on the six month anniversary of the 2020 Date of Grant, a further 20% vested on the nine month anniversary of the 2020 Date of Grant, and the final 20% vested on the year anniversary of the 2020 Date of Grant, in accordance with that certain option agreement entered into by and between the Issuer and the reporting person and the NanoVibronix, Inc. 2014 Long-Term Incentive Plan.

SEC source: 0001493152-23-043638 · ownership.xml · derivative · entry 4

Goldstein Martin M · CIK 0001639061 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,500 shares

Expires 2030-10-01

F6 · price: The options were canceled by mutual agreement of the reporting person and NanoVibronix, Inc. The reporting person received $1.00 as the aggregate consideration for the cancellations.

SEC source: 0001493152-23-043638 · ownership.xml · derivative · entry 3

Goldstein Martin M · CIK 0001639061 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,125 shares

Expires 2030-07-13

F6 · price: The options were canceled by mutual agreement of the reporting person and NanoVibronix, Inc. The reporting person received $1.00 as the aggregate consideration for the cancellations.

SEC source: 0001493152-23-043638 · ownership.xml · derivative · entry 2

Goldstein Martin M · CIK 0001639061 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 4,575 shares

Expires 2035-03-25

F6 · price: The options were canceled by mutual agreement of the reporting person and NanoVibronix, Inc. The reporting person received $1.00 as the aggregate consideration for the cancellations.

F2 · derivative.exercise_date: 20% of the option vested on March 25, 2015 (the "2015 Date of Grant"), with an additional 20% vested on the three month anniversary of the 2015 Date of Grant, a further 20% vested on the six month anniversary of the 2015 Date of Grant, a further 20% vested on the nine month anniversary of the 2015 Date of Grant, and the final 20% vested on the year anniversary of the 2015 Date of Grant, in accordance with that certain option agreement entered into by and between the Issuer and the reporting person and the NanoVibronix, Inc. 2014 Long-Term Incentive Plan.

SEC source: 0001493152-23-043634 · ownership.xml · derivative · entry 3

JACOB HAROLD · CIK 0001443692 · Director · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,500 shares

Expires 2032-09-13

F4 · price: The options were canceled by mutual agreement of the reporting person and NanoVibronix, Inc. The reporting person received $1.00 as the aggregate consideration for the cancellations.

F3 · derivative.exercise_date: 25% of the option vested on September 13, 2022 (the "2022 Date of Grant"), with an additional 25% to vest on the three-month anniversary of the 2022 Date of Grant, a further 25% to vest on the six-month anniversary of the 2022 Date of Grant, and the final 25% to vest on the nine-month anniversary of the 2022 Date of Grant, in accordance with that certain option agreement entered into by and between the Issuer and the reporting person and the NanoVibronix, Inc. 2014 Long-Term Incentive Plan.

SEC source: 0001493152-23-043634 · ownership.xml · derivative · entry 2

JACOB HAROLD · CIK 0001443692 · Director · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,500 shares

Expires 2031-12-29

F4 · price: The options were canceled by mutual agreement of the reporting person and NanoVibronix, Inc. The reporting person received $1.00 as the aggregate consideration for the cancellations.

F2 · derivative.exercise_date: 25% of the option vested on December 29, 2021 (the "2021 Date of Grant"), with an additional 25% to vest on the three-month anniversary of the 2021 Date of Grant, a further 25% to vest on the six-month anniversary of the 2021 Date of Grant, and the final 25% to vest on the nine-month anniversary of the 2021 Date of Grant, in accordance with that certain option agreement entered into by and between the Issuer and the reporting person and the NanoVibronix, Inc. 2014 Long-Term Incentive Plan.

SEC source: 0001493152-23-043633 · ownership.xml · derivative · entry 6

MIKA THOMAS · CIK 0001263576 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 3,000 shares

Expires 2031-12-29

F5 · price: The options were canceled by mutual agreement of the reporting person and NanoVibronix, Inc. The reporting person received $1.00 as the aggregate consideration for the cancellations.

F4 · derivative.exercise_date: 25% of the option vested on December 29, 2021 (the " 2021 Date of Grant"), with an additional 25% vested on the three-month anniversary of the 2021 Date of Grant, a further 25% vested on the six-month anniversary of the 2021 Date of Grant, and the final 25% vested on the nine-month anniversary of the 2021 Date of Grant, in accordance with that certain option agreement entered into by and between the Issuer and the reporting person and the NanoVibronix, Inc. 2014 Long-Term Incentive Plan.

SEC source: 0001493152-23-043633 · ownership.xml · derivative · entry 5

MIKA THOMAS · CIK 0001263576 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 4,500 shares

Expires 2030-12-22

F5 · price: The options were canceled by mutual agreement of the reporting person and NanoVibronix, Inc. The reporting person received $1.00 as the aggregate consideration for the cancellations.

F3 · derivative.exercise_date: 20% of the option vested on December 22, 2020 (the "2020 Date of Grant"), with an additional 20% vested on the three month anniversary of the 2020 Date of Grant, a further 20% vested on the six month anniversary of the 2020 Date of Grant, a further 20% vested on the nine month anniversary of the 2020 Date of Grant, and the final 20% vested on the year anniversary of the 2020 Date of Grant, in accordance with that certain option agreement entered into by and between the Issuer and the reporting person and the NanoVibronix, Inc. 2014 Long-Term Incentive Plan.

SEC source: 0001493152-23-043633 · ownership.xml · derivative · entry 4

MIKA THOMAS · CIK 0001263576 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,000 shares

Expires 2030-10-01

F5 · price: The options were canceled by mutual agreement of the reporting person and NanoVibronix, Inc. The reporting person received $1.00 as the aggregate consideration for the cancellations.

SEC source: 0001493152-23-043633 · ownership.xml · derivative · entry 3

MIKA THOMAS · CIK 0001263576 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 3,000 shares

Expires 2032-09-13

F5 · price: The options were canceled by mutual agreement of the reporting person and NanoVibronix, Inc. The reporting person received $1.00 as the aggregate consideration for the cancellations.

F2 · derivative.exercise_date: 25% of the option vested on September 13, 2022 (the "2022 Date of Grant"), with an additional 25% to vest on the three-month anniversary of the 2022 Date of Grant, a further 25% to vest on the six-month anniversary of the 2022 Date of Grant, and the final 25% to vest on the nine-month anniversary of the 2022 Date of Grant, in accordance with that certain option agreement entered into by and between the Issuer and the reporting person and the NanoVibronix, Inc. 2014 Long-Term Incentive Plan.

SEC source: 0001493152-23-043633 · ownership.xml · derivative · entry 2

MIKA THOMAS · CIK 0001263576 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,500 shares

Expires 2030-07-13

F5 · price: The options were canceled by mutual agreement of the reporting person and NanoVibronix, Inc. The reporting person received $1.00 as the aggregate consideration for the cancellations.

SEC source: 0001493152-23-043637 · ownership.xml · derivative · entry 5

BROWN STEPHEN RUSSELL · CIK 0001246334 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 5,000 shares

Expires 2031-12-29

F5 · price: The options were canceled by mutual agreement of the reporting person and NanoVibronix, Inc. The reporting person received $1.00 as the aggregate consideration for the cancellations.

F4 · derivative.exercise_date: 25% of the option vested on December 29, 2021 (the " 2021 Date of Grant"), with an additional 25% vested on the three-month anniversary of the 2021 Date of Grant, a further 25% vested on the six-month anniversary of the 2021 Date of Grant, and the final 25% vested on the nine-month anniversary of the 2021 Date of Grant, in accordance with that certain option agreement entered into by and between the Issuer and the reporting person and the NanoVibronix, Inc. 2014 Long-Term Incentive Plan.

SEC source: 0001493152-23-043637 · ownership.xml · derivative · entry 4

BROWN STEPHEN RUSSELL · CIK 0001246334 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,500 shares

Expires 2030-12-22

F5 · price: The options were canceled by mutual agreement of the reporting person and NanoVibronix, Inc. The reporting person received $1.00 as the aggregate consideration for the cancellations.

F3 · derivative.exercise_date: 20% of the option vested on December 22, 2020 (the "2020 Date of Grant"), with an additional 20% vested on the three month anniversary of the 2020 Date of Grant, a further 20% vested on the six month anniversary of the 2020 Date of Grant, a further 20% vested on the nine month anniversary of the 2020 Date of Grant, and the final 20% vested on the year anniversary of the 2020 Date of Grant, in accordance with that certain option agreement entered into by and between the Issuer and the reporting person and the NanoVibronix, Inc. 2014 Long-Term Incentive Plan.

SEC source: 0001493152-23-043637 · ownership.xml · derivative · entry 3

BROWN STEPHEN RUSSELL · CIK 0001246334 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,500 shares

Expires 2030-10-01

F5 · price: The options were canceled by mutual agreement of the reporting person and NanoVibronix, Inc. The reporting person received $1.00 as the aggregate consideration for the cancellations.

SEC source: 0001493152-23-043637 · ownership.xml · derivative · entry 2

BROWN STEPHEN RUSSELL · CIK 0001246334 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 563 shares

Expires 2028-08-14

F5 · price: The options were canceled by mutual agreement of the reporting person and NanoVibronix, Inc. The reporting person received $1.00 as the aggregate consideration for the cancellations.

F2 · derivative.exercise_date: The option vested in two equal installments as follows: (i) 1/2 of the total shares on November 1, 2018, and (ii) 1/2 of the total shares on November 1, 2019.

SEC source: 0001493152-23-043632 · ownership.xml · derivative · entry 2

Schroeder Maria · CIK 0001906106 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,500 shares

Expires 2032-09-13

F3 · price: The options were canceled by mutual agreement of the reporting person and NanoVibronix, Inc. The reporting person received $1.00 as the aggregate consideration for the cancellations.

F2 · derivative.exercise_date: 25% of the option vested on September 13, 2022 (the "2022 Date of Grant"), with an additional 25% to vest on the three-month anniversary of the 2022 Date of Grant, a further 25% to vest on the six-month anniversary of the 2022 Date of Grant, and the final 25% to vest on the nine-month anniversary of the 2022 Date of Grant, in accordance with that certain option agreement entered into by and between the Issuer and the reporting person and the NanoVibronix, Inc. 2014 Long-Term Incentive Plan.

SEC source: 0001493152-23-043636 · ownership.xml · derivative · entry 2

Cassirer Aurora · CIK 0001905696 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,500 shares

Expires 2032-09-13

F3 · price: The options were canceled by mutual agreement of the reporting person and NanoVibronix, Inc. The reporting person received $1.00 as the aggregate consideration for the cancellations.

F2 · derivative.exercise_date: 25% of the option vested on September 13, 2022 (the "2022 Date of Grant"), with an additional 25% to vest on the three-month anniversary of the 2022 Date of Grant, a further 25% to vest on the six-month anniversary of the 2022 Date of Grant, and the final 25% to vest on the nine-month anniversary of the 2022 Date of Grant, in accordance with that certain option agreement entered into by and between the Issuer and the reporting person and the NanoVibronix, Inc. 2014 Long-Term Incentive Plan.

SEC source: 0001493152-23-043635 · ownership.xml · derivative · entry 5

Ferguson Michael · CIK 0001607534 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,875 shares

Expires 2032-09-13

F5 · price: The options were canceled by mutual agreement of the reporting person and NanoVibronix, Inc. The reporting person received $1.00 as the aggregate consideration for the cancellations.

F4 · derivative.exercise_date: 25% of the option vested on September 13, 2022 (the "2022 Date of Grant"), with an additional 25% to vest on the three-month anniversary of the 2022 Date of Grant, a further 25% to vest on the six-month anniversary of the 2022 Date of Grant, and the final 25% to vest on the nine-month anniversary of the 2022 Date of Grant, in accordance with that certain option agreement entered into by and between the Issuer and the reporting person and the NanoVibronix, Inc. 2014 Long-Term Incentive Plan.

SEC source: 0001493152-23-043635 · ownership.xml · derivative · entry 4

Ferguson Michael · CIK 0001607534 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,875 shares

Expires 2031-12-29

F5 · price: The options were canceled by mutual agreement of the reporting person and NanoVibronix, Inc. The reporting person received $1.00 as the aggregate consideration for the cancellations.

F3 · derivative.exercise_date: 25% of the option vested on December 29, 2021 (the " 2021 Date of Grant"), with an additional 25% vested on the three-month anniversary of the 2021 Date of Grant, a further 25% vested on the six-month anniversary of the 2021 Date of Grant, and the final 25% vested on the nine-month anniversary of the 2021 Date of Grant, in accordance with that certain option agreement entered into by and between the Issuer and the reporting person and the NanoVibronix, Inc. 2014 Long-Term Incentive Plan.

SEC source: 0001493152-23-043635 · ownership.xml · derivative · entry 3

Ferguson Michael · CIK 0001607534 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 4,250 shares

Expires 2030-12-22

F5 · price: The options were canceled by mutual agreement of the reporting person and NanoVibronix, Inc. The reporting person received $1.00 as the aggregate consideration for the cancellations.

F2 · derivative.exercise_date: 20% of the option vested on December 22, 2020 (the "2020 Date of Grant"), with an additional 20% vested on the three month anniversary of the 2020 Date of Grant, a further 20% vested on the six month anniversary of the 2020 Date of Grant, a further 20% vested on the nine month anniversary of the 2020 Date of Grant, and the final 20% vested on the year anniversary of the 2020 Date of Grant, in accordance with that certain option agreement entered into by and between the Issuer and the reporting person and the NanoVibronix, Inc. 2014 Long-Term Incentive Plan.

SEC source: 0001493152-23-043635 · ownership.xml · derivative · entry 2

Ferguson Michael · CIK 0001607534 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,750 shares

Expires 2030-10-01

F5 · price: The options were canceled by mutual agreement of the reporting person and NanoVibronix, Inc. The reporting person received $1.00 as the aggregate consideration for the cancellations.

SEC source: 0001493152-23-043893 · ownership.xml · derivative · entry 5

Murphy Brian M · CIK 0001687795 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 15,000 shares

Expires 2031-12-29

F5 · price: The options were canceled by mutual agreement of the reporting person and NanoVibronix, Inc. The reporting person received $1.00 as the aggregate consideration for the cancellations

F4 · derivative.exercise_date: 25% of the option vested on December 29, 2021 (the " 2021 Date of Grant"), with an additional 25% vested on the three-month anniversary of the 2021 Date of Grant, a further 25% vested on the six-month anniversary of the 2021 Date of Grant, and the final 25% vested on the nine-month anniversary of the 2021 Date of Grant, in accordance with that certain option agreement entered into by and between the Issuer and the reporting person and the NanoVibronix, Inc. 2014 Long-Term Incentive Plan.

SEC source: 0001493152-23-043893 · ownership.xml · derivative · entry 4

Murphy Brian M · CIK 0001687795 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 10,000 shares

Expires 2030-12-22

F5 · price: The options were canceled by mutual agreement of the reporting person and NanoVibronix, Inc. The reporting person received $1.00 as the aggregate consideration for the cancellations

F3 · derivative.exercise_date: 20% of the option vested on December 22, 2020 (the "2020 Date of Grant"), with an additional 20% vested on the three month anniversary of the 2020 Date of Grant, a further 20% vested on the six month anniversary of the 2020 Date of Grant, a further 20% vested on the nine month anniversary of the 2020 Date of Grant, and the final 20% vested on the year anniversary of the 2020 Date of Grant, in accordance with that certain option agreement entered into by and between the Issuer and the reporting person and the NanoVibronix, Inc. 2014 Long-Term Incentive Plan.

SEC source: 0001493152-23-043893 · ownership.xml · derivative · entry 3

Murphy Brian M · CIK 0001687795 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,500 shares

Expires 2030-10-01

F5 · price: The options were canceled by mutual agreement of the reporting person and NanoVibronix, Inc. The reporting person received $1.00 as the aggregate consideration for the cancellations

SEC source: 0001493152-23-043893 · ownership.xml · derivative · entry 2

Murphy Brian M · CIK 0001687795 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,875 shares

Expires 2028-08-14

F5 · price: The options were canceled by mutual agreement of the reporting person and NanoVibronix, Inc. The reporting person received $1.00 as the aggregate consideration for the cancellations

F2 · derivative.exercise_date: The option vested in two equal installments as follows: (i) 1/2 of the total shares on November 1, 2018, and (ii) 1/2 of the total shares on November 1, 2019.

SEC source: 0001493152-23-043892 · ownership.xml · derivative · entry 6

FASHEK CHRISTOPHER M · CIK 0001279063 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 4,000 shares

Expires 2031-12-28

F5 · price: The options were canceled by mutual agreement of the reporting person and NanoVibronix, Inc. The reporting person received $1.00 as the aggregate consideration for the cancellations.

F4 · derivative.exercise_date: 25% of the option vested on December 29, 2021 (the "2021 Date of Grant"), with an additional 25% vested on the three-month anniversary of the 2021 Date of Grant, a further 25% vested on the six-month anniversary of the 2021 Date of Grant, and the final 25% vested on the nine-month anniversary of the 2021 Date of Grant, in accordance with that certain option agreement entered into by and between the Issuer and the reporting person and the NanoVibronix, Inc. 2014 Long-Term Incentive Plan.

SEC source: 0001493152-23-043892 · ownership.xml · derivative · entry 5

FASHEK CHRISTOPHER M · CIK 0001279063 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 6,000 shares

Expires 2030-12-22

F5 · price: The options were canceled by mutual agreement of the reporting person and NanoVibronix, Inc. The reporting person received $1.00 as the aggregate consideration for the cancellations.

F3 · derivative.exercise_date: 20% of the option vested on December 22, 2020 (the "2020 Date of Grant"), with an additional 20% vested on the three month anniversary of the 2020 Date of Grant, a further 20% vested on the six month anniversary of the 2020 Date of Grant, a further 20% vested on the nine month anniversary of the 2020 Date of Grant, and the final 20% vested on the year anniversary of the 2020 Date of Grant, in accordance with that certain option agreement entered into by and between the Issuer and the reporting person and the NanoVibronix, Inc. 2014 Long-Term Incentive Plan.

SEC source: 0001493152-23-043892 · ownership.xml · derivative · entry 4

FASHEK CHRISTOPHER M · CIK 0001279063 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,500 shares

Expires 2030-10-01

F5 · price: The options were canceled by mutual agreement of the reporting person and NanoVibronix, Inc. The reporting person received $1.00 as the aggregate consideration for the cancellations.

SEC source: 0001493152-23-043892 · ownership.xml · derivative · entry 3

FASHEK CHRISTOPHER M · CIK 0001279063 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,100 shares

Expires 2030-07-07

F5 · price: The options were canceled by mutual agreement of the reporting person and NanoVibronix, Inc. The reporting person received $1.00 as the aggregate consideration for the cancellations.

SEC source: 0001493152-23-043892 · ownership.xml · derivative · entry 2

FASHEK CHRISTOPHER M · CIK 0001279063 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,125 shares

Expires 2028-08-14

F5 · price: The options were canceled by mutual agreement of the reporting person and NanoVibronix, Inc. The reporting person received $1.00 as the aggregate consideration for the cancellations.

F2 · derivative.exercise_date: The option vested in two equal installments as follows: (i) 1/2 of the total shares on November 1, 2018, and (ii) 1/2 of the total shares on November 1, 2019.

SEC source: 0001493152-23-043638 · ownership.xml · derivative · entry 1

Goldstein Martin M · CIK 0001639061 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,333

Underlying: Common Stock · 3,333 shares

Expires 2033-11-15

F1 · derivative.exercise_date: 100% of the option vested on November 15, 2023, in accordance with that certain option agreement entered into by and between the Issuer and the reporting person and the NanoVibronix, Inc. 2014 Long-Term Incentive Plan.

SEC source: 0001493152-23-043634 · ownership.xml · derivative · entry 1

JACOB HAROLD · CIK 0001443692 · Director · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,333

Underlying: Common Stock · 3,333 shares

Expires 2033-11-15

F1 · derivative.exercise_date: 100% of the option vested on November 15, 2023, in accordance with that certain option agreement entered into by and between the Issuer and the reporting person and the NanoVibronix, Inc. 2014 Long-Term Incentive Plan.

SEC source: 0001493152-23-043633 · ownership.xml · derivative · entry 1

MIKA THOMAS · CIK 0001263576 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,334

Underlying: Common Stock · 3,334 shares

Expires 2033-11-15

F1 · derivative.exercise_date: 100% of the option vested on November 15, 2023, in accordance with that certain option agreement entered into by and between the Issuer and the reporting person and the NanoVibronix, Inc. 2014 Long-Term Incentive Plan.

SEC source: 0001493152-23-043637 · ownership.xml · derivative · entry 1

BROWN STEPHEN RUSSELL · CIK 0001246334 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,000

Underlying: Common Stock · 14,000 shares

Expires 2033-11-15

F1 · derivative.exercise_date: 100% of the option vested on November 15, 2023, in accordance with that certain option agreement entered into by and between the Issuer and the reporting person and the NanoVibronix, Inc. 2014 Long-Term Incentive Plan.

SEC source: 0001493152-23-043632 · ownership.xml · derivative · entry 1

Schroeder Maria · CIK 0001906106 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,333

Underlying: Common Stock · 3,333 shares

Expires 2033-11-15

F1 · derivative.exercise_date: 100% of the option vested on November 15, 2023, in accordance with that certain option agreement entered into by and between the Issuer and the reporting person and the NanoVibronix, Inc. 2014 Long-Term Incentive Plan.

SEC source: 0001493152-23-043636 · ownership.xml · derivative · entry 1

Cassirer Aurora · CIK 0001905696 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,333

Underlying: Common Stock · 3,333 shares

Expires 2033-11-15

F1 · derivative.exercise_date: 100% of the option vested on November 15, 2023, in accordance with that certain option agreement entered into by and between the Issuer and the reporting person and the NanoVibronix, Inc. 2014 Long-Term Incentive Plan.

SEC source: 0001493152-23-043635 · ownership.xml · derivative · entry 1

Ferguson Michael · CIK 0001607534 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,334

Underlying: Common Stock · 3,334 shares

Expires 2023-11-15

F1 · derivative.exercise_date: 100% of the option vested on November 15, 2023, in accordance with that certain option agreement entered into by and between the Issuer and the reporting person and the NanoVibronix, Inc. 2014 Long-Term Incentive Plan.

SEC source: 0001493152-23-043893 · ownership.xml · derivative · entry 1

Murphy Brian M · CIK 0001687795 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Common Stock · 20,000 shares

Expires 2023-11-15

F1 · derivative.exercise_date: 100% of the option vested on November 15, 2023, in accordance with that certain option agreement entered into by and between the Issuer and the reporting person and the NanoVibronix, Inc. 2014 Long-Term Incentive Plan.

SEC source: 0001493152-23-043892 · ownership.xml · derivative · entry 1

FASHEK CHRISTOPHER M · CIK 0001279063 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,000

Underlying: Common Stock · 14,000 shares

Expires 2033-11-15

F1 · derivative.exercise_date: 100% of the option vested on November 15, 2023, in accordance with that certain option agreement entered into by and between the Issuer and the reporting person and the NanoVibronix, Inc. 2014 Long-Term Incentive Plan.

SEC source: 0001493152-23-000609 · ownership.xml · nonDerivative · entry 1

MIKA THOMAS · CIK 0001263576 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,000

SEC source: 0001493152-22-017169 · ownership.xml · nonDerivative · entry 1

FASHEK CHRISTOPHER M · CIK 0001279063 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 75,000

F1 · balance_after: Reflects shares of common stock the reporting person purchased on November 20, 2019, which were inadvertently excluded from the Form 4 filed on September 29, 2020.

SEC source: 0001493152-22-016736 · ownership.xml · nonDerivative · entry 1

BROWN STEPHEN RUSSELL · CIK 0001246334 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,000

SEC source: 0001493152-22-015656 · ownership.xml · nonDerivative · entry 1

Cassirer Aurora · CIK 0001905696 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,000

SEC source: 0001493152-21-032872 · ownership.xml · derivative · entry 1

Goldstein Martin M · CIK 0001639061 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Stock · 50,000 shares

Expires 2031-12-28

F1 · derivative.exercise_date: 25% of the option vested on December 29, 2021 (the "Date of Grant"), with an additional 25% to vest on the three-month anniversary of the Date of Grant, a further 25% to vest on the six-month anniversary of the Date of Grant, and the final 25% to vest on the nine-month anniversary of the Date of Grant, in accordance with that certain option agreement entered into by and between the Issuer and the reporting person and the NanoVibronix, Inc. 2014 Long-Term Incentive Plan.

SEC source: 0001493152-21-032877 · ownership.xml · derivative · entry 1

BROWN STEPHEN RUSSELL · CIK 0001246334 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Common Stock · 100,000 shares

Expires 2031-12-28

F1 · derivative.exercise_date: The option vests in 12 equal installments on each three-month anniversary of the grant date (December 29, 2021), in accordance with that certain option agreement entered into by and between the Issuer and the reporting person and the NanoVibronix, Inc. 2014 Long-Term Incentive Plan.

SEC source: 0001493152-21-032873 · ownership.xml · derivative · entry 1

Ferguson Michael · CIK 0001607534 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 57,500

Underlying: Common Stock · 57,500 shares

Expires 2031-12-28

F1 · derivative.exercise_date: 25% of the option vested on December 29, 2021 (the "Date of Grant"), with an additional 25% to vest on the three-month anniversary of the Date of Grant, a further 25% to vest on the six-month anniversary of the Date of Grant, and the final 25% to vest on the nine-month anniversary of the Date of Grant, in accordance with that certain option agreement entered into by and between the Issuer and the reporting person and the NanoVibronix, Inc. 2014 Long-Term Incentive Plan.

SEC source: 0001493152-22-000078 · ownership.xml · derivative · entry 1

Murphy Brian M · CIK 0001687795 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 300,000

Underlying: Common Stock · 300,000 shares

Expires 2031-12-28

F1 · derivative.exercise_date: The option vests in 12 equal installments on each three-month anniversary of the grant date (December 29, 2021), in accordance with that certain option agreement entered into by and between the Issuer and the reporting person and the NanoVibronix, Inc. 2014 Long-Term Incentive Plan.

SEC source: 0001493152-22-000081 · ownership.xml · derivative · entry 1

JACOB HAROLD · CIK 0001443692 · Director · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Stock · 50,000 shares

Expires 2031-12-28

F1 · derivative.exercise_date: 25% of the option vested on December 29, 2021 (the "Date of Grant"), with an additional 25% to vest on the three-month anniversary of the Date of Grant, a further 25% to vest on the six-month anniversary of the Date of Grant, and the final 25% to vest on the nine-month anniversary of the Date of Grant, in accordance with that certain option agreement entered into by and between the Issuer and the reporting person and the NanoVibronix, Inc. 2014 Long-Term Incentive Plan.

SEC source: 0001493152-22-000073 · ownership.xml · derivative · entry 1

FASHEK CHRISTOPHER M · CIK 0001279063 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 80,000

Underlying: Common Stock · 80,000 shares

Expires 2031-12-28

F1 · derivative.exercise_date: 25% of the option vested on December 29, 2021 (the "Date of Grant"), with an additional 25% to vest on the three-month anniversary of the Date of Grant, a further 25% to vest on the six-month anniversary of the Date of Grant, and the final 25% to vest on the nine-month anniversary of the Date of Grant, in accordance with that certain option agreement entered into by and between the Issuer and the reporting person and the NanoVibronix, Inc. 2014 Long-Term Incentive Plan.

SEC source: 0001493152-22-000075 · ownership.xml · derivative · entry 1

MIKA THOMAS · CIK 0001263576 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 60,000

Underlying: Common Stock · 60,000 shares

Expires 2031-12-28

F1 · derivative.exercise_date: 25% of the option vested on December 29, 2021 (the "Date of Grant"), with an additional 25% to vest on the three-month anniversary of the Date of Grant, a further 25% to vest on the six-month anniversary of the Date of Grant, and the final 25% to vest on the nine-month anniversary of the Date of Grant, in accordance with that certain option agreement entered into by and between the Issuer and the reporting person and the NanoVibronix, Inc. 2014 Long-Term Incentive Plan.